Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPY-Kidney: Fluorescence Angiography in Kidney Transplantation
NCT02775838Phase 2Completed
- Sponsor
- University Hospital Erlangen
- Start
- Apr 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in kidney failure (ESRD), sponsored by University Hospital Erlangen. Primary endpoint: Correlation of intraoperative SPY Perfusion Parameters with short-term outcome of the graft function at 24 months. Started Apr 2016; status: completed.
02
Drugs
indocyanine green
03
Conditions
kidney failure (ESRD)
Beyond the preview
Go deeper on NCT02775838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02775838.